Skip to content

Author

Nikolaos Kotsopoulos

We have 2 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Societal and fiscal gains from HPV vaccination in Poland - return on investment from extending access to HPV vaccination.

Expanding HPV vaccination eligibility and coverage in Poland is expected to generate substantial societal and fiscal returns and not only reduces the burden of HPV-related diseases and associated mortality but also delivers a strong and sustainable return on investment.

Rafał Jaworski, Nikolaos Kotsopoulos, Marcin Czech et al. · 0 citations
Open access Aug 2026

Unlocking the value of RSV vaccination in Japan: a return on investment analysis using an integrated actuarial-macroeconomic model

Overall, adjuvanted RSVPreF3 vaccination among older adults in Japan represents good value for money from a societal perspective, where vaccine acquisition and administration costs are expected to be outweighed by substantial health, productivity, and broader economic benefits.

Eleftherios Zarkadoulas, A. Akimoto, Deven Chauhan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.